IP Library Assignment 042464/0407
Patent Assignment
Reel/Frame 042464/0407

Assignment of Assignor's Interest

Recorded: 2017-05-13 Pages: 8
Assignor
ACTELION PHARMACEUTICALS LTD
Executed: 2017-05-09
Assignee
IDORSIA PHARMACEUTICALS LTD
HAGENHEIMERMATTWEG 91, ALLSCHWIL, CH-4123, SWITZERLAND
Covered Properties (109)
1,2,3,4-Tetrahydroisoquinoline Derivatives
Patent: 6,703,392 →
Application: 10/239,693 →
Publication: US 2003/0176415
Piperidinetriol Derivatives as Inhibitors of Glycosylceramidsynthase
Patent: 7,994,198 →
Application: 10/522,207 →
Publication: US 2006/0111400
Piperidinetriol Derivatives as Inhibitors of Glycosyceramid Synthase
Patent: 7,985,760 →
Application: 10/522,208 →
Publication: US 2006/0058349
2-Hydroxymethyl-3,4,5-Trihydroxy-1-(4-Pentyloxybenzyl) Piperidine as Glucosylceramide Synthase (Gcs) Inhibitor
Patent: 8,022,219 →
Application: 10/560,383 →
Publication: US 2007/0259918
2-Hydroxymethyl-3,4,5-Trihydroxy-1-Benzilpiperidine Derivatives as Inhibitors of Glucosylceramide
Patent: 8,071,780 →
Application: 10/560,385 →
Publication: US 2007/0112028
Substituted 1,2,3,4-Tetrahydroisoquinoline Derivatives
Patent: 7,763,638 →
Application: 10/598,449 →
Publication: US 2007/0191424
Tetrahydropyridoindole Derivatives
Patent: 7,714,132 →
Application: 10/598,777 →
Publication: US 2007/0191416
2,3,4,9- Tetrahydro-1H-Carbazole Derivatives as CRTH2 Receptor Antagonists
Patent: 8,039,474 →
Application: 11/722,095 →
Publication: US 2009/0270414
Hydrogenated Benzo (C) Thiophene Derivatives as Immunomodulators
Patent: 7,723,378 →
Application: 11/909,429 →
Publication: US 2008/0176926
Pyrimidine Derivatives and Their Use as P2Y12 Receptor Antagonists
Patent: 8,048,881 →
Application: 11/912,545 →
Publication: US 2008/0194576
Novel Piperazines as Antimalarial Agents
Patent: 8,067,419 →
Application: 12/090,816 →
Publication: US 2008/0234272
Ethanol or 1,2-Ethanediol Cyclohexyl Antibiotic Derivatives
Patent: 7,820,655 →
Application: 12/279,329 →
Publication: US 2009/0005368
Pyridin-4-Yl Derivatives as Immunomodulating Agents
Patent: 8,580,824 →
Application: 12/310,801 →
Publication: US 2010/0063108
(3-Amino-1,2,3,4-Tetrahydro-9H-Carbazol-9-Yl)-Acetic Acid Derivatives
Patent: 8,143,304 →
Application: 12/376,932 →
Publication: US 2010/0190830
2-Aminocarbonyl-Pyridine Derivatives
Patent: 8,093,250 →
Application: 12/445,352 →
Publication: US 2010/0035895
2-Phenyl-6-Aminocarbonyl-Pyrimidine Derivatives and Their Use as P2Y12 Receptor
Patent: 8,044,055 →
Application: 12/447,039 →
Publication: US 2009/0291962
Trisubstituted 3,4-Dihydro-1H-Isoquinolin Compound, Process for Its Preparation, and Its Use
Patent: 8,247,560 →
Application: 12/497,023 →
Publication: US 2010/0010226
4-(1-Amino-Ethyl)-Cyclohexylamine Derivatives
Patent: 8,044,044 →
Application: 12/520,580 →
Publication: US 2010/0029623
Oxazolidinone Antibiotic Derivatives
Patent: 8,114,867 →
Application: 12/595,711 →
Publication: US 2010/0137290
Oxazolidinone Antibiotics
Patent: 8,217,029 →
Application: 12/595,720 →
Publication: US 2011/0039823
Bridged Six-Membered Ring Compounds
Patent: 8,202,885 →
Application: 12/597,817 →
Publication: US 2010/0130545
3-Amino-6-(1-Amino-Ethyl)-Tetrahydropyran Derivatives
Patent: 8,193,179 →
Application: 12/664,828 →
Publication: US 2010/0179135
4-Pyrimidinesulfamide Derivative
Patent: 8,324,232 →
Application: 12/673,413 →
Publication: US 2012/0142716
Tetrahydroquinoline Derivatives for Treating Post-Traumatic Stress Disorders
Patent: 9,532,985 →
Application: 12/681,802 →
Publication: US 2010/0234420
Phosphonic Acid Derivates and Their Use as P2Y12 Receptor Antagonists
Patent: 8,518,912 →
Application: 12/745,358 →
Publication: US 2010/0261678
Hydrogenated Benzo (C) Thiophene Derivatives as Immunomodulators
Patent: 8,039,644 →
Application: 12/749,180 →
Publication: US 2010/0204198
Aminopyrazole Derivatives
Patent: 8,288,419 →
Application: 12/808,137 →
Publication: US 2011/0034516
Aminotriazole Derivatives as Alx Agonists
Patent: 8,536,209 →
Application: 12/809,545 →
Publication: US 2010/0331378
5-Aminocyclylmethyl-Oxazolidin-2-One Derivatives
Patent: 9,505,750 →
Application: 12/809,555 →
Publication: US 2011/0003789
Process for the Preparation of an Enantiomeric Trisubstituted 3,4-Dihydro-Isoquinoline Derivative
Patent: 8,314,238 →
Application: 12/810,176 →
Publication: US 2010/0305325
Azatricyclic Antibiotic Compounds
Patent: 8,349,828 →
Application: 12/918,749 →
Publication: US 2010/0331318
Oxazolidinone Derivatives
Patent: 8,349,826 →
Application: 12/918,779 →
Publication: US 2010/0331308
Pyridin-2-Yl Derivatives as Immunomodulating Agents
Patent: 8,575,200 →
Application: 12/920,656 →
Publication: US 2010/0331372
Substituted 2-Phenyl-Pyridine Derivatives
Patent: 8,058,263 →
Application: 12/936,661 →
Publication: US 2011/0046089
2-Phenyl-4-Cyclopropyl-Pyrimidine Derivatives
Patent: 8,466,156 →
Application: 12/936,664 →
Publication: US 2011/0028484
3,4-Substituted Piperidine Derivatives as Renin Inhibitors
Patent: 8,889,714 →
Application: 12/990,927 →
Publication: US 2011/0053940
[4-(1-Amino-Ehtyl) - Cyclohexyl] -Methyl-Amine and [6-(1-Amino-Ehtyl) -Tetrahydro-Pyran-3-Yl] -Methyl-Amine Derivatives as Antibacterials
Patent: 8,349,829 →
Application: 12/996,360 →
Publication: US 2011/0082132
Tricyclic Oxazolidinone Antibiotic Compounds
Patent: 8,618,092 →
Application: 13/123,218 →
Publication: US 2011/0195961
Oxazolidinyl Antibiotics
Patent: 8,507,478 →
Application: 13/123,708 →
Publication: US 2011/0201595
Salts of Isobutyric Acid (1 R*, 2R*, 4R*) -2- (2-{ [3-(4,7-Dimethoxy-1 H-Benzoimidazol-2-Yl) -Methyl-Amino } - Ethyl)-5-Phenyl-Bicyclo [2.2.2] Oct-5- En-2-Yl Ester
Patent: 8,492,555 →
Application: 13/125,443 →
Publication: US 2011/0263667
5-Amino-2-(1-Hydroxy-Ethyl)-Tetrahydropyran Derivatives
Patent: 8,211,890 →
Application: 13/139,179 →
Publication: US 2011/0245259
6-(3-Aza-Bicyclo[3.1.0]Hex-3-Yl)-2-Phenyl-Pyrimidines
Patent: 8,288,385 →
Application: 13/263,089 →
Publication: US 2012/0028989
2-Hydroxyethyl-1H-Quinolin-2-One Derivatives and Their Azaisosteric Analogues with Antibacterial Activity
Patent: 8,415,375 →
Application: 13/263,922 →
Publication: US 2012/0040989
Thiazole Derivatives and Their Use as P2Y12 Receptor Antagonists
Patent: 8,664,203 →
Application: 13/265,493 →
Publication: US 2012/0053149
Novel Oxazolidinone Deriviatives
Patent: 8,329,706 →
Application: 13/319,780 →
Publication: US 2012/0101111
Bridged Spiro [2.4] Heptane Derivatives as Alx Receptor and/or FPRL2 Agonists
Patent: 8,563,714 →
Application: 13/321,372 →
Publication: US 2012/0115841
Fluorinated Aminotriazole Derivatives
Patent: 8,580,831 →
Application: 13/376,966 →
Publication: US 2012/0101138
Pyridin-4-Yl Derivatives
Patent: 8,658,675 →
Application: 13/383,619 →
Publication: US 2012/0108638
Method for Identifying Modulators of Gpcr GPR1 Function
Patent: 8,709,734 →
Application: 13/499,896 →
Publication: US 2012/0202221
Piperazines as Antimalarial Agents
Patent: 8,889,688 →
Application: 13/519,938 →
Publication: US 2012/0316178
3-(Heteroaryl-Amino)-1,2,3,4-Tetrahydro-9H-Carbazole Derivatives and Their Use as Prostaglandin D2 Receptor Modulators
Patent: 8,697,869 →
Application: 13/637,005 →
Publication: US 2013/0065902
1-Phenyl-Substituted Heterocyclyl Derivatives and Their Use as Prostaglandin D2 Receptor Modulators
Patent: 8,575,158 →
Application: 13/808,857 →
Publication: US 2013/0109685
Proline Sulfonamide Derivatives as Orexin Receptor Antagonists
Patent: 8,895,606 →
Application: 13/818,647 →
Publication: US 2013/0150424
Neuropeptide Q as Modulator of Gpcr GALR2 and Uses Thereof
Patent: 9,057,726 →
Application: 13/876,447 →
Publication: US 2013/0196348
Diastereoselective Preparation of Bicyclo[2.2.2]Octan-2-One Compounds
Patent: 8,816,118 →
Application: 13/880,486 →
Publication: US 2013/0289295
Preparation of Bicyclo[2.2.2]Octan-2-One Compounds
Patent: 9,296,673 →
Application: 13/880,520 →
Publication: US 2013/0211104
Lactam Derivatives Useful as Orexin Receptor Antagonists
Patent: 9,242,970 →
Application: 13/884,741 →
Publication: US 2013/0237525
2-Methoxy-Pyridin-4-Yl-Derivatives
Patent: 9,133,179 →
Application: 13/980,764 →
Publication: US 2013/0303514
Bridged Spiro[2.4]heptane Ester Derivatives
Patent: 9,187,435 →
Application: 13/988,204 →
Publication: US 2013/0231319
Oxazolyl-Methylether Derivatives as Alx Receptor Agonists
Patent: 8,846,733 →
Application: 13/992,143 →
Publication: US 2013/0261159
Hydroxylated Aminotriazole Derivatives as ALX Receptor Agonists
Patent: 9,346,793 →
Application: 13/992,156 →
Publication: US 2013/0267569
Novel Pyrazole and Imidazole Derivatives Useful as Orexin Antagonists
Patent: 9,303,023 →
Application: 14/000,172 →
Publication: US 2013/0324579
Tricyclic Oxazolidinone Antibiotic Compounds
Patent: 9,346,804 →
Application: 14/096,419 →
Publication: US 2014/0142093
7-(Heteroaryl-Amino)-6,7,8,9-Tetrahydropyrido[1,2-A]Indol Acetic Acid Derivatives and Their Use as Prostaglandin D2 Receptor Modulators
Patent: 9,096,595 →
Application: 14/111,889 →
Publication: US 2014/0045870
Heterocyclic Amide Derivatives as P2X7 Receptor Antagonists
Patent: 9,221,832 →
Application: 14/234,250 →
Publication: US 2014/0163035
2-Oxo-Oxazolidin-3,5-Diyl Antibiotic Derivatives
Patent: 9,079,922 →
Application: 14/356,896 →
Publication: US 2015/0051188
2-(1,2,3-Triazol-2-Yl)Benzamide and 3-(1,2,3-Triazol-2-Yl)Picolinamide Derivatives as Orexin Receptor Antagonists
Patent: 9,150,566 →
Application: 14/357,159 →
Publication: US 2015/0158855
Heterocyclyl Derivatives and their use as Prostaglandin D2 Receptor Modulators
Patent: 9,255,090 →
Application: 14/367,823 →
Publication: US 2015/0252036
Heterocyclic Amide Derivatives as P2X7 Receptor Antagonists
Patent: 9,409,917 →
Application: 14/373,338 →
Publication: US 2015/0025075
4-(Benzoimidazol-2-yl)-thiazole Compounds and Related Aza Derivatives
Patent: 9,266,876 →
Application: 14/376,307 →
Publication: US 2014/0371204
Fluorinated Bridged Spiro[2.4]Heptane Derivatives as ALX Receptor Agonists
Patent: 9,139,524 →
Application: 14/401,769 →
Publication: US 2015/0118258
1-(p-tolyl)cyclopropyl substituted Bridged Spiro[2.4]Heptane Derivatives as ALX Receptor Agonists
Patent: 9,284,288 →
Application: 14/401,774 →
Publication: US 2015/0141482
Benzimidazole-Proline Derivatives
Patent: 9,732,075 →
Application: 14/405,649 →
Publication: US 2015/0166527
1-[m-Carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide Derivatives
Patent: 9,428,456 →
Application: 14/410,426 →
Publication: US 2015/0336893
1-Phenyl-Substituted Heterocyclyl Derivatives and Their Use as Prostaglandin D2 Receptor Modulators
Patent: 9,169,270 →
Application: 14/412,877 →
Publication: US 2015/0158883
Orexin Receptor Antagonists Which Are [Ortho Bi-(Hetero-)Aryl]-[2-(Meta Bi-(Hetero-)Aryl)-Pyrrolidin-1-Yl]-Methanone Derivatives
Patent: 9,493,446 →
Application: 14/434,997 →
Publication: US 2015/0252032
Proline Sulfonamide Derivatives as Orexin Receptor Antagonists
Patent: 9,000,029 →
Application: 14/530,532 →
Publication: US 2015/0057328
Proline Sulfonamide Derivatives as Orexin Receptor Antagonists
Patent: 9,211,279 →
Application: 14/639,934 →
Publication: US 2015/0246021
Indole Carboxamide Derivatives as P2X7 Receptor Antagonist
Patent: 9,718,774 →
Application: 14/651,922 →
Publication: US 2015/0322008
Indole Carboxamide Derivatives as P2X7 Receptor Antagonists
Patent: 9,556,117 →
Application: 14/653,363 →
Publication: US 2015/0344425
Difluoroethyl-oxazole sustituted bridged spiro[2.4]heptane derivatives as alx receptor agonists
Patent: 9,676,761 →
Application: 14/757,491 →
Publication: US 2016/0289221
Heterocyclic Amide Derivatives as P2X7 Receptor Antagonists
Patent: 9,388,197 →
Application: 14/762,692 →
Publication: US 2015/0361096
Heterocyclic Amide Derivatives as P2X7 Receptor Antagonists
Patent: 9,388,198 →
Application: 14/762,717 →
Publication: US 2015/0361097
Azetidine Amide Derivatives as Orexin Receptor Antagonists
Patent: 9,403,813 →
Application: 14/775,474 →
Publication: US 2016/0024064
Pyridin-4-Yl Derivatives
Patent: 9,617,250 →
Application: 14/777,444 →
Publication: US 2016/0031866
Novel Acrylamide Derivatives as Antimalarial Agents
Patent: 9,637,473 →
Application: 14/777,459 →
Publication: US 2016/0024050
Antibacterial Biaromatic Derivatives
Patent: 9,527,867 →
Application: 14/784,602 →
Publication: US 2016/0075722
Quinolone Derivatives
Patent: 9,540,399 →
Application: 14/888,581 →
Publication: US 2016/0060276
CXCR7 Receptor Modulators
Patent: 9,920,010 →
Application: 14/892,959 →
Publication: US 2016/0107997
Device for Dispensing a Fluid to a Patient
Application: 14/894,114 →
Publication: US 2016/0121043
Piperazine Substituted Bridged Spiro[2.4]Heptane Derivatives as Alx Receptor Agonists
Patent: 9,533,964 →
Application: 14/905,768 →
Publication: US 2016/0152584
1-(Piperazin-1-Yl)-2-([1,2,4]Triazol-1-Yl)-Ethanone Derivatives
Application: 14/906,882 →
Publication: US 2016/0176862
Benzimidazolyl-Methyl Urea Derivatives as Alx Receptor Agonists
Patent: 9,663,473 →
Application: 14/911,000 →
Publication: US 2016/0200686
Dosing Appratus for Dispensing a Fluid Under Aseptic Conditions
Application: 15/006,285 →
Publication: US 2016/0213851
Antibacterial 2H-Indazole Derivatives
Patent: 9,802,901 →
Application: 15/021,649 →
Publication: US 2016/0221959
Crystalline Form of (S)-(2-(6-Chloro-7-Methyl-1H-Benzo[D]Imidazol-2-Yl)-2-Methylpyrrolidin-1 -Yl)(5-Methoxy-2-(2H-1,2,3-Triazol-2-Yl)Phenyl)Methanone and Its Use as Orexin Receptor Antagonists
Patent: 9,914,720 →
Application: 15/101,768 →
Publication: US 2016/0368901
Crystalline Salt Form of (S)-(2-(6-Chloro-7-Methyl-1H-Benzo[D]Imidazol-2-Yl)-2-Methylpyrrolidin-1-Yl) (5-Methoxy-2-(2H-1,2,3-Triazol-2-Yl)Phenyl)Methanone as Orexin Receptor Antagonist
Patent: 9,790,208 →
Application: 15/101,832 →
Publication: US 2016/0355506
Use of Benzimidazole-Proline Derivatives
Patent: 9,914,721 →
Application: 15/101,871 →
Publication: US 2017/0001985
Antibacterial 1H-Indazole and 1H-Indole Derivatives
Patent: 9,624,206 →
Application: 15/106,790 →
Publication: US 2017/0029411
Process for Manufacturing Pyrimidine Sulfamide Derivatives
Patent: 9,938,244 →
Application: 15/118,046 →
Publication: US 2016/0368882
1,2-Dihydro-3H-Pyrrolo[1,2-C]Imidazol-3-One Derivatives and Their Use as Antibacterial Agents
Application: 15/123,184 →
Publication: US 2017/0107223
Azaindole Acetic Acid Derivatives and Their Use as Prostaglandin D2 Receptor Modulators
Patent: 9,879,006 →
Application: 15/125,018 →
Publication: US 2017/0022196
Azaindole Acetic Acid Derivatives and Their Use as Prostaglandin D2 Receptor Modulators
Patent: 9,850,241 →
Application: 15/127,361 →
Publication: US 2017/0129884
8-(Piperazin-1-Yl)-1,2,3,4-Tetrahydro-Isoquinoline Derivatives
Patent: 9,951,063 →
Application: 15/128,846 →
Publication: US 2017/0107214
Tricyclic Oxazolidinone Antibiotic Compounds
Patent: 9,822,114 →
Application: 15/135,352 →
Publication: US 2016/0237088
Antibacterial Quinazoline-4(3H)-One Derivatives
Patent: 9,796,686 →
Application: 15/311,758 →
Publication: US 2017/0081292
Pyrazole Compounds and Their Use as T-Type Calcium Channel Blockers
Patent: 9,932,314 →
Application: 15/316,100 →
Publication: US 2017/0096399
Triazole Compounds as T-Type Calcium Channel Blockers
Application: 15/510,980 →
Publication: US 2018/0230109
Antibacterial Basic Biaromatic Derivatives with Aminoalkoxy Substitution
Patent: 9,850,256 →
Application: 15/516,290 →
Publication: US 2017/0305927
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 24, 2003
From: AISSAOUI, HAMED; CAPPI, MICHAEL; CLOZEL, MARTINE; FISCHLI, WALTER
To: ACTELION PHARMACEUTICAL LTD.
Reel/Frame 013800/0499 →
Assignment of Assignor's Interest Oct 27, 2005
From: ALI, MEZHER HUSSEIN; ORCHARD, MICHAEL GLEN
To: OXFORD GLYCOSCIENCES (UK) LTD.
Reel/Frame 016950/0354 →
Assignment of Assignor's Interest Oct 27, 2005
From: ALI, MEZHER HUSSEIN; ORCHARD, MICHAEL GLEN
To: OXFORD GLYCOSCIENCES (UK) LTD.
Reel/Frame 016950/0318 →
Assignment of Assignor's Interest Apr 13, 2006
From: ORCHARD, MICHAEL GLEN; SCOPES, DAVID IAN CARTER
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 017789/0299 →
Assignment of Assignor's Interest Aug 1, 2006
From: OXFORD GLYCOSCIENCES (UK) LIMITED
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 018044/0675 →
Assignment of Assignor's Interest Aug 1, 2006
From: OXFORD GLYCOSCIENCES (UK) LIMITED
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 018045/0532 →
Assignment of Assignor's Interest Sep 1, 2006
From: AISSAOUI, HAMED; CLOZEL, MARTINE; FISCHLI, WALTER; KOBERSTEIN, RALF
To: ACTELION PHARMACEUTICALS, LTD.
Reel/Frame 018261/0266 →
Assignment of Assignor's Interest Oct 12, 2006
From: FECHER, ANJA; FRETZ, HEINZ; HILPERT, KURT; RIEDERER, MARKUS
To: ACTELION PHARMACEUTICALS, LTD.
Reel/Frame 018409/0951 →
Assignment of Assignor's Interest Jan 19, 2007
From: ORCHARD, MICHAEL G.
To: ACTELION PHARMACEUTICALS, LTD.
Reel/Frame 018830/0359 →
Assignment of Assignor's Interest Oct 4, 2007
From: BOLLI, MARTIN; LEHMANN, DAVID; MATHYS, BORIS; MUELLER, CLAUS
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 019921/0823 →
Assignment of Assignor's Interest Oct 22, 2007
From: FECHER, ANJA; FRETZ, HEINZ; RIEDERER, MARKUS
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 020019/0941 →
Assignment of Assignor's Interest Jan 23, 2008
From: CAROFF, EVA; FRETZ, HEINZ; HILPERT, KURT; HOUILLE, OLIVIER
To: ACTELION PHARMACEUTICALS, LTD.
Reel/Frame 020435/0883 →
Assignment of Assignor's Interest May 2, 2008
From: BINKERT, CHRISTOPH; BOSS, CHRISTOPH; CORMINBOEUF, OLIVIER; GRISOSTOMI, CORINNA
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 020958/0207 →
Corrective Assignment to Correct the Serial Number Previously Recorded on Reel 021384 Frame 0377. Assignor(S) Hereby Confirms the Assignment in U.S. Application No. 12/279,329. Aug 19, 2008
From: HUBSCHWERLEN, CHRISTIAN; SURIVET, JEAN-PHILIPPE; ZUMBRUNN ACKLIN, CORNELIA
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 021406/0166 →
Assignment of Assignor's Interest Feb 9, 2009
From: FRETZ, HEINZ; POTHIER, JULIEN; RISCH, PHILIPPE
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 022227/0995 →
Assignment of Assignor's Interest Jan 12, 2010
From: DE VRIES, MARIA ANDREAS HENDRIKUS; DOMIN, DORIS; HELMS, MATTHIAS; IMBODEN, CHRISTOPH
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 023764/0926 →
Assignment of Assignor's Interest Nov 8, 2010
From: CAROFF, EVA; HILPERT, KURT; MEYER, EMMANUEL
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 025330/0746 →
Assignment of Assignor's Interest Nov 22, 2011
From: CAROFF, EVA; HILPERT, KURT; MEYER, EMMANUEL
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 027269/0090 →
Assignment of Assignor's Interest Apr 26, 2012
From: BOLLI, MARTIN; LEHMANN, DAVID; MATHYS, BORIS; MUELLER, CLAUS
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 028109/0315 →
Assignment of Assignor's Interest Sep 28, 2015
From: BOLLI, MARTIN; LESCOP, CYRILLE; NAYLER, OLIVER; STEINER, BEAT
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 036672/0304 →
Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 042464 Frame: 0407. Assignor(S) Hereby Confirms the Assignment. Jun 28, 2017
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 043017/0022 →
Assignment of Assignor's Interest Jun 6, 2024
From: IDORSIA PHARMACEUTICALS LTD.
To: VIATRIS ASIA PACIFIC PTE. LTD.
Reel/Frame 067647/0303 →